Secular Trends of Species and Antimicrobial Resistance of Blood Isolates in a Tertiary Medical Center for Ten Years: 2003~2012

  • Shin, Kyeong Seob (Department of Laboratory Medicine, Chungbuk National University College of Medicine) ;
  • Son, Young Il (Department of Laboratory Medicine, Chungbuk National University College of Medicine) ;
  • Kim, Yong Dae (Department of Preventive Medicine, Chungbuk National University College of Medicine) ;
  • Hong, Seung Bok (Department of Clinical Laboratory Science, Chungbuk Health & Science University) ;
  • Park, Je-Seop (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University) ;
  • Kim, Sunghyun (Institute for Life Science and Biotechnology, Yonsei University) ;
  • Yu, Young-Bin (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University) ;
  • Kim, Young Kwon (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University)
  • 투고 : 2014.06.13
  • 심사 : 2014.06.30
  • 발행 : 2014.06.30

초록

Periodic analysis of local epidemiologic data of prevalent pathogens of blood culture can provide clinicians with relevant information to guide empirical antibiotic therapy. In this study, we analyzed a pattern of change of causative microorganisms and antimicrobial resistance at a tertiary medical center in Chungcheong province from 2003 to 2012, retrospectively. Of 70,258 blood specimens cultured, 6,063 (8.6%) were positive. Among the positive isolates, 95.9% were aerobic or facultative anaerobic bacteria, 0.1% were anaerobes, and 3.9% were fungi. Coagulase-negative Staphylococci (CoNS) (32.9%), Escherichia coli (16.7%), Staphylococcus aureus (9.1%), Klebsiella pneumoniae (6.4%), and ${\alpha}$-hemolytic Streptococcus (5.9%) were commonly isolated bacteria, and Candida albicans (1.4%) was the most commonly isolated fungi. Enterococcus faecium progressively increased but Streptococcus pneumoniae, Acinetobacter baumannii and Proteus species gradually decreased over a period of 10 years. The multidrug-resistant microorganisms such as methicillin-resistant S. aureus (MRSA), vancomycin-resistant enterococci (VRE), cefotaxime-resistant E. coli, imipenem-resistant Pseudomonas aeruginosa (IRPA) and imipenem-resistant A. baumannii (IRAB), were significantly increased. Therefore, there is a need for a more strict control of antibiotics and a more updated guideline for the treatment of bloodstream infection.

키워드

참고문헌

  1. Ahn GY, Jang SJ, Lee SH, Jeong OY, Chaulagain BP, Moon DS, Park YJ. Trends of the species and antimicrobial susceptibility of microorganisms isolated from blood culture of patients. Korean J Clin Microbiol. 2006. 9: 42-60.
  2. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med. 1996. 22: 387-394. https://doi.org/10.1007/BF01712153
  3. Behrendt G, Schneider S, Brodt HR, Just-Nubling G, Shah PM. Influence of antimicrobial treatment on mortality in septicemia. J Chemother. 1999. 11: 179-186. https://doi.org/10.1179/joc.1999.11.3.179
  4. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 1994. 32: 1148-1153.
  5. Bush K. New $\beta$-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infec Dis. 2001. 32: 1085-1089. https://doi.org/10.1086/319610
  6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty two informational supplement (M100-S22). Wayne, PA: CLSI, 2012.
  7. Chung G, Cha J, Han S, Jang II, Lee K, Yoo J, Kim H, Eun S, Kim B, Park O, Lee YS. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006. J Microbiol Biotechnol. 2010. 20: 637-642.
  8. Empey KM, Rapp RP, Evans ME. The effect of an antimicrobial formulary change on hospital resistance patterns. Pharmacotherapy. 2002. 22: 81-87. https://doi.org/10.1592/phco.22.1.81.33508
  9. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000. 118: 146-155. https://doi.org/10.1378/chest.118.1.146
  10. Jacoby GA, Medeiros AA. More extended-spectrum $\beta$-lactamase. Antimicrob Agents Chemother. 1991. 35: 1697-1704. https://doi.org/10.1128/AAC.35.9.1697
  11. Jeong HW, Son BR, Shin DI, Rye D, Hong SB, Han K, Shin KS. Characterization of Acinetobacter baumannii co-producing carbapenemase OXA-23 and OXA-66, and armA 16S ribosomal RNA methylase at a university hospital in South Korea. Korean J Clin Microbiol. 2011. 14: 67-73. https://doi.org/10.5145/KJCM.2011.14.2.67
  12. Jones RN, Guzman-Blanco M, Gales AC, Gallegros B, Castro ALL, Martino MDV, Vega S, Zurita J, Cepparulo M, Castanheira M. Susceptibility rates in Latin American nations: report from regional resistance surveillance program (2011). Braz Infect Dis. 2013. 17: 672-681. https://doi.org/10.1016/j.bjid.2013.07.002
  13. Jones RN, Flonta M, Gurler N, Cepparulo M, Mendes RE, Castanheira M. Resistance surveillance program report for selected European nations (2011). Diagn Microbiol Infect Dis. 2014. 78: 429-436. https://doi.org/10.1016/j.diagmicrobio.2013.10.008
  14. Kang SH, Kim YR. Characteristics of microorganisms isolated from blood culture at a university hospital located in an island region during 2003-2007. Korean J Clin Microbio. 2008. 11: 11-17. https://doi.org/10.5145/KJCM.2008.11.1.11
  15. Kim HK, Lee KW, Chong YS, Kwon OH, Kim JM, Kim DS. Blood culture results at the Severance Hospital during 1984-1993. Infect Chemother 1996. 28: 151-166.
  16. Kim HO, Kang CG, Chong YS, Lee SY. Organisms isolated from blood at the Yonsei Medical Center, 1974-1983. Infect Chemother. 1985. 17: 15-32.
  17. Kim MN. Multidrug-resistant organisms and healthcare-associated infections. Hanyang Med Rev. 2011. 31: 141-152. https://doi.org/10.7599/hmr.2011.31.3.141
  18. Kim NH, Hwang JH, Song KH, Choe PG, Park WB, Kim ES, Park SW, Kim HB, Kim NJ, Oh MD, Kim EC. Changes in antimicrobial susceptibility of blood isolates in a university hospital in South Korea, 1998-2010. Infect Chemother. 2012. 44: 275-281. https://doi.org/10.3947/ic.2012.44.4.275
  19. Kim SY, Shin J, Shin SY, Ko KS. Characteristics of carbapenemresistant Enterobacteriaceae isolates from Korea. Diagn Microbiol Infect Dis. 2013. 76: 486-490. https://doi.org/10.1016/j.diagmicrobio.2013.04.006
  20. Koh EM, Lee SG, Kim CK, Kim M, Yong D, Lee K, Kim JM, Kim DS, Chong Y. Microorganisms isolated from blood cultures and their antimicrobial susceptibility pattern at a university hospital during 1994-2003. Korean J Lab Med. 2007. 27: 265-275. https://doi.org/10.3343/kjlm.2007.27.4.265
  21. Kolar M, Vagnerova I, Latal T, Urbanek K, Typovska H, Hubacek J, Papajik T, Raida L, Faber E. The occurrence of vancomycinresistant enterococci in hematological patients in relation to antibiotic use. New Microbiol. 2002. 25: 373-379.
  22. Lee K, Kim MN, Choi TY, Cho SE, Lee S, Whang DH. Yong D, Chong Y, Woodford N, Livermore DM. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Intern J Antimicrob Agents. 2009. 33: 520-524. https://doi.org/10.1016/j.ijantimicag.2008.10.009
  23. Lee K, Yong D, Jeong SH, Chong Y. Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J. 2011. 52: 879-891. https://doi.org/10.3349/ymj.2011.52.6.879
  24. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003. 348: 1546-1554. https://doi.org/10.1056/NEJMoa022139
  25. Mendes RE, Mendoza M, Banga Singh KK, Castanheira M, Bell JM, Turnidge JD, Lin SS, Jones RN. Regional resistance surveillance program results for 12 Asia-Pacific nations (2011). Antimicrob Agents Chemother. 2013. 57: 5721-576. https://doi.org/10.1128/AAC.01121-13
  26. Nordmann P, Nass T, Poirel L. Global spread of carbapenemaseproducing Enterobactericeae. Emerg Infect Dis 2011. 17: 1791-1798. https://doi.org/10.3201/eid1710.110655
  27. Quale J, Landman D, Atwood E, Kreiswirth B, Willey BM, Ditore V, Zaman M, Patel K, Saurina G, Huang W, Oydna E, Burney S. Experience with a hospital-wide outbreak of vancomycin resistant enterococci. Am J Infect Control. 1996. 24: 373-379.
  28. Ramphal R, Ambrose PG. Extended-spectrum $\beta$-lactamases and clinical outcomes: current data. Clin Infect Dis. 2006. 42: S164-S172. https://doi.org/10.1086/500663
  29. Shin KS, Son BR, Hong SB, Kim J. Dipicolinic acid-based disk methods for detection of metallo-$\beta$-lactamase-producing Pseudomonas spp. and Acinetobacter spp. Diagn Microbiol Infect Dis. 2008. 62: 102-105. https://doi.org/10.1016/j.diagmicrobio.2008.04.015
  30. Tokars JI. Predictive value of blood cultures positive for coagulasenegative staphylococci: implications for patient care and health care quality assurance. Clin Infect Dis. 2004. 39: 331-341.
  31. Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. 2001. 7: 174-177. https://doi.org/10.3201/eid0702.010203
  32. Yinnon AM, Schlesinger Y, Gabbay D, Rudensky B. Analysis of 5 years of bacteremias: importance of stratification of microbial susceptibilities by source of patients. J Infect. 1997. 35: 17-23. https://doi.org/10.1016/S0163-4453(97)90857-4